$MPT

Hanna James Kevin purchased $10K of MPT

Hanna James Kevin (Senior VP, Controller & CAO) purchased 2,300 shares of MEDICAL PROPERTIES TRUST INC (MPT) at $4.15 on 2026-08-20.

Original reporting
SEC EDGAR · Hanna James Kevin
Published Aug 20, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MPT
Neutral
high confidence
Mentioned
$MPT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MPTNeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to move the stock significantly, but it adds to the cumulative insider activity record.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or earnings could give more context to the insider's confidence.

Relevance 4/10Novelty 5/10Timing: filed today

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of insider confidence.

Company-level read

Ticker impact

$MPTNeutralHigh confidence
Context

Senior VP Hanna James Kevin purchased 2,300 shares of Medical Properties Trust for $9,545, filing a Form 4 on 2026-08-20.

Expected impact

Minimal short-term price movement expected.

Evidence & confidence

The transaction is a primary disclosure (Form 4) but the amount is under $10K, typical for routine insider activity.

Market effects

Limited effect on REIT sector; typical insider activity.

No significant regional impact.

Not globally relevant.

Counterpoint

The purchase may be a routine compensation action rather than a strong bullish signal.

Key entities

  • Medical Properties Trust Inc.

    US-listed REIT focused on healthcare properties.

  • Hanna James Kevin

    Senior Vice President, Controller & CAO at Medical Properties Trust.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MPTMedAI 8/10

Medical Properties Trust (MPT) Q2 2026 Earnings Call Transcript

Medical Properties Trust (MPT) held its Q2 2026 earnings call. The company said it announced a refinancing extending $2.4 billion of debt maturities to 2032 and targeting over $1 billion annualized cash rent by year end. MPT reported normalized FFO of $0.15/share. Portfolio EBITDARM coverage was 2.8x (general acute), 2.4x (post-acute), and 1.4x (behavioral).

$MPTMed

MPT Down on Releasing Q2 Figures

Medical Properties Trust (NYSE: MPT) reported Q2 2026 results for the quarter ended June 30, 2026. It announced a private offering of about $2.4B of secured notes to repay debt, including 2026 notes and about 50% of 2027 notes. It expects about $172M cash from asset sales in Q3, plus $100M from Infracore SA IPO and $35M later. Q2 net loss was $0.01 per share, normalized FFO $0.15 per share, and it paid a $0.09 dividend.

$MPTMedAI 8/10

Medical Properties Trust (NYSE: MPT) extends debt to 2032 with $2.4B refinancing

Medical Properties Trust (MPT) reported Q2 2026 total revenues of $259.3 million and a net loss of $2.6 million, versus a $98.4 million loss a year earlier. Normalized FFO was $92.2 million. After quarter end, its operating partnership agreed to issue $2.4 billion of 9.25% senior secured notes due 2032 to refinance maturities and reduce principal debt by about $123 million.